Clinical Trial Update: Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Zanubrutinib in combination with Odronextamab for Richter transformation in transformed chronic lymphocytic leukemia; recruitment ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Richter Syndrome

Drugs mentioned

• Odronextamab (odronextamab)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia | Phase 1 | Status: RECRUITING